Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cronos Group

Being a cannabis stock pessimist was a profitable venture this year.

Short Sellers Made $791 Million in 2019 by Betting Against These 4 Pot Stocks

HEXO Corp

Major pot producers and their beer partners have a full lineup of CBD drinks poised to hit store shelves.

Canopy, HEXO, and Tilray Have Marijuana Drinks Ready to Roll in Canada

Collectively, investors lost almost $10 billion on these pot stocks since the year began.

3 Marijuana Stocks That Cost Investors Billions in 2019

Aphria

Cannabis stocks had a huge showing on Wall Street last year. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Yield on Cannabis Stocks

The bubble for this popular pot stock has now completely deflated.

This Cannabis Stock Has Come Full Circle After 17 Months

It has been a brutal year for cannabis investors. Heading into 2020, cannabis investors are now weighing whether to cut their losses or buy the dip in a bet on a rebound ahead.

Will Cannabis Stocks Bounce Back In 2020?

Neptune Wellness Solutions Inc.

The stocks are more reasonably priced and trading at better valuations, but could they fall even further?

3 Pot Stocks Near Their 52-Week Lows: Is It Time to Buy?

Switzerland becomes the 14th country to receive medical cannabis product from the company.

Tilray Breaks Into a New Market in Europe

OrganiGram Holdings Inc.

Valuations have been dropping and it could be a good opportunity for cannabis investors to take advantage of some relatively low prices.

Is Now the Time to Buy These 3 Pot Stocks?

Tilray, Inc. (NASDAQ: TLRY) subsidiary High Park Holdings Ltd. announced its line of Cannabis 2.0 products Tuesday.

Tilray Launches Canadian Cannabis 2.0 Products, Completes First Export Of Medical Cannabis Extract To Switzerland

TLRY stock is down big since the passage of the MORE Act, and that's a sign of more troubles to come for Tilray stock.
The post Why There’s No Rush to Buy Tilray Stock Anytime Soon appeared first on InvestorPlace.

Why There’s No Rush to Buy Tilray Stock Anytime Soon

EnWave stock is worth a look for marijuana stock investors fed up with companies that are consistently drowning in a sea of red ink.

Aurora Cannabis and Tilray's Technology Provider's Q4 Revenue Soars 120%

Anheuser-Busch InBev

Curaleaf Holdings, Inc.

GW Pharmaceuticals

The U.S. Food and Drug Administration's consumer update on CBD isn't the death knell it's made out to be.

4 Things to Know About the FDA's CBD Guidance

The marijuana company and Privateer Holdings are now one and the same.

Tilray Locks In a Merger With a Major Shareholder

Tilray Inc (NASDAQ: TLRY) said Friday that its merger with the private equity firm Privateer Holdings closed the previous day.

Tilray, Privateer Holdings Close Merger Deal

Amplify Alternative Harvest ETF

REX Shares has launched two cannabis-related ETNs, one among which is double leveraged. Is the launch untimely?

Is REX Shares' Leveraged Cannabis ETN Launch Untimely?

Pot stocks were a little higher on Friday after the Ontario government announced that it will abandon the current lottery system for cannabis retail.

Pot Stocks on the Move After New Ontario Licensing Deal

MedMen Enterprises Inc.

Cannabis stocks rallied out of the gate Friday, after a report that the Canadian province of Ontario will open up the market for retailers with plans to issue abut 20 new store approvals starting in April of 2020. The news reported by Canadian network CBC eased concerns about the shortage of stores that has hampered the development of the legal cannabis market in Canada and allowed the black market to continue to thrive.

Cannabis stocks rally out of the gate on report Ontario to open market for store openings

Caution and cash conservation were the prevailing themes at MJBizCon, after marijuana stocks crashed this year amid concerns of a shakeout ahead.

Investors In Marijuana Stocks Say This Is What Industry Must Do To Survive

Altria

Pot stocks comprise five of the 50 most-held stocks on millennial-focused investment app Robinhood.

The 5 Most Popular Cannabis Stocks Among Millennials

When pot stocks failed to live up to heightened expectations, investors panicked out of the sector.

10 Hot Pot Stocks to Buy

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Marijuana stock market caps continue to shrink.

There Are Only 9 Billion-Dollar Pot Stocks Left

Mattel

Veteran toy industry executive Katy Dickson will head the company's crucial hemp unit.

Tilray Taps Ex-Mattel Exec for Key Role in Subsidiary

The Food and Drug Administration cautions that "CBD has the potential to harm you" in a newly released consumer update.

The FDA's Stance on CBD Should Surprise No One

Qutoutiao Inc - ADR

trivago

A marijuana stock, a Chinese dot-com, and a global hotel portal have lost more than half of their value in 2019.

News for Tilray Brands Stock (TLRY)